AIM ImmunoTech Inc

NYSE American: AIM
Share price (4/26/24): $0.43
Market cap (4/26/24): $21.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Initial registration of new securities

Exempt offering of securities – amended

Exempt offering of securities

Registration of securities for employees

Registration of securities on exchange – amended

Ownership Filter

Rodino Peter W III

Equels Thomas K

Rodino Peter W III

Equels Thomas K

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Reports Positive Topline Results From Phase 2 Study Evaluating Ampligen® for the Treatment of Post-Covid Conditions

Material Disclosure, Financial Statements or Exhibits

Shareholder Vote Results

Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (Rintatolimod) in Combination With AstraZeneca’s Imfinzi® (Durvalumab) for the Treatment of Pancreatic Cancer

Proxies Filter

Proxy materials by non-management

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC